Christopher P. Leamon

Author

Also Known As

C P Leamon, C. Leamon, C.P. Leamon, Christopher Leamon, Christopher P Leamon, Christopher P. Leamon, Leamon, Christopher P

153

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

Endocyte (United States)Purdue University West Lafayette Paul Scherrer Institute University of Maryland, Baltimore

About

Christopher P. Leamon is an author at Endocyte (United States) specializing in medicine, pharmacology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	36	4.3K
2	Biochemistry	17	19	1.7K
3	Natural Sciences	13	13	1.6K
4	Health Sciences	3	3	145
5	Engineering	2	2	213

Christopher P. Leamon

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Nikki Parker, Mary Jo Turk, Elaine Westrick, Analytical Biochemistry Tumor BiologyNormal TissuesMalignant DiseaseMedicineFolate Receptor Expression	2005	1.2K
Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Christopher P. Leamon, Philip S. Low Proceedings of the National Academy of Sciences Lipid PeroxidationCell CultureCellular PhysiologyOxidative StressRegenerative Medicine	1991	557
Folate-mediated targeting: from diagnostics to drug and gene delivery Christopher P. Leamon, Philip S. Low Drug Discovery Today Drug TargetingMedicineTumor TargetingFolate-mediated TargetingDrug Development	2001	368
PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer R. Wendel Naumann, Robert L. Coleman, Robert A. Burger, Journal of Clinical Oncology	2013	227
Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery Chrystal M. Paulos, Joseph A. Reddy, Christopher P. Leamon, Molecular Pharmacology	2004	216
Synthesis and Biological Evaluation of EC20: A New Folate-Derived, <sup>99m</sup>Tc-Based Radiopharmaceutical Christopher P. Leamon, Matthew Parker, Iontcho R. Vlahov, Bioconjugate Chemistry	2002	207
Folate-Liposome-Mediated Antisense Oligodeoxynucleotide Targeting to Cancer Cells: Evaluation in Vitro and in Vivo Christopher P. Leamon, Scott Cooper, Gregory E. Hardee Bioconjugate Chemistry EngineeringPeg ChainFolate MoietyTumor BiologyNanomedicine	2003	181
Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors Joseph A. Reddy, C Abburi, Hans Hofland, Gene Therapy Cancer ResearchExtracellular MicrovesiclesTumor TargetingMedicineCell Biology	2002	173
Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain. Christopher P. Leamon, Ira Pastan, Philip S. Low Journal of Biological Chemistry Tumor CellsChemical BiologyTumor BiologyProtein SynthesisEndocytic Pathway	1993	168
Preclinical Evaluation of EC145, a Folate-<i>Vinca</i> Alkaloid Conjugate Joseph A. Reddy, Ryan Dorton, Elaine Westrick, Cancer Research	2007	167

Page 1